Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001641172-25-018540
Filing Date
2025-07-10
Accepted
2025-07-10 09:28:46
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1496
  Complete submission text file 0001641172-25-018540.txt   2959
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Issuer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CELULARITY INC. 170 PARK AVE FLORHAM PARK NJ 07932
Business Address
LeVien Vincent (Reporting) CIK: 0002076464 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38914 | Film No.: 251114992